Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors?
BMC Infectious Diseases volume 14, Article number: 692 (2014)
Detection of fungal DNA from formalin-fixed, paraffin-embedded (FFPE) tissue is challenging due to degradation of DNA and presence of PCR inhibitors in these samples. We analyzed FFPE samples of 26 patients by panfungal PCR and compared the results to the composite diagnosis according to the European Organization for Research and Treatment of Cancer (EORTC) criteria. Additionally we analyzed the quality of human and fungal DNA and their level of age-dependent degradation, as well as the existence of PCR inhibition in these tissue samples.
We evaluated two 45-cycle panfungal PCR tests that target the internal transcribed spacer 2 (ITS2) as well as the ITS1-5.8S-ITS2 (ITS1-2) region. The PCRs were applied to 27 FFPE specimens from 26 patients with proven invasive fungal disease (IFD), and one patient with culture and histologically negative but PCR-positive fungal infection collected at our institution from 2003 to 2010. Quality of DNA in FFPE tissue samples was evaluated using fragments of the beta-globin gene for multiplex PCR, inhibition of PCR amplification was evaluated by spiking of C. krusei DNA to each PCR premix.
In 27 FFPE samples the ITS2 PCR targeting the shorter fragment showed a higher detection rate with a sensitivity of 53.8% compared to the ITS1-2 fragment (sensitivity 38%). Significant time-dependent degradation of human DNA in FFPE sample extracts was detected based on partial beta-globin gene amplification which was not in correlation to successful panfungal PCR identification of fungal organisms. The analytical sensitivity of both assays compared with culture was 60 CFU/ml of a Candida krusei reference strain. The performance of the two tests in an Aspergillus proficiency panel of an international external quality assessment programme showed considerable sensitivity.
Panfungal diagnostic PCR assays applied on FFPE specimens provide accurate identification of molds in highly degraded tissue samples and correct identification in samples stored up to 7 years despite sensitivity limitations, mainly caused by partial PCR inhibition and DNA degradation by formalin.
Invasive fungal disease (IFD), especially in case of delayed initiation of appropriate antifungal treatment, is associated with severe morbidity and high mortality in immunocompromised, critically-ill patients . Early and precise identification of fungal pathogens is crucial for appropriate management of patients with IFD as typical clinical manifestations often lack . Despite detection of fungal elements in histological samples, fungal cultures from tissue biopsies often remain negative ,. An appealing alternative for culture-independent identification of the fungal agent might be panfungal PCR performed retrospectively from FFPE tissue. However, isolating high-quality DNA from FFPE biopsies is difficult because of the DNA degrading activity of the routinely used fixative formalin. Efficiency of DNA amplification from FFPE material also depends on the time period for fixation ,.
The two fungal internal transcribed spacer regions 1 (ITS1) and 2 (ITS2) are highly variable and can be amplified by PCR using broad-range panfungal primers detecting potentially all fungal organisms . The sequence analysis followed by comparison with reference sequences in databases enables the identification of the etiologic organism in many cases to the species level. The detection rates of different panfungal PCR approaches in FFPE tissue specimens compared with conventional techniques have been reported in previous studies to be 51% to 62.7% -. In the study of Paterson et al.  the molecular detection of the fungal pathogens could be raised to 93% when combining PCR with hybridization. However storage time to of the FFPE specimens was not specified in many of the studies mentioned ,,,.
The aim of the present study was the evaluation of two diagnostic panfungal PCR detection systems based on ITS amplification followed by sequencing for the identification of fungal pathogens in 26 culturally or histologically proven cases of IFD and one additional PCR positive case in FFPE tissue specimens. Molecular results from the FFPE samples were compared with the composite diagnosis according to the European Organization for Research and Treatment of Cancer (EORTC) criteria . We especially aimed to analyze the quality of human and fungal DNA in FFPE samples and their level of age-dependent degradation, as well as the existence of PCR inhibition in these tissue samples.
Clinical specimens from patients with proven IFD
The University Hospital of Basel is a tertiary referral 950-bed institution serving north western Switzerland with a population of approximately half a million people. From 2003 to 2010 27 FFPE biopsy samples from sterile sites of 26 hospitalized patients with proven IFD were collected and retrospectively analyzed. The biopsies were all performed for diagnostic purpose without any link to our study. The study was approved by the local ethical committee (Ethische Komission beider Basel, EKBB). Proven IFD was defined by use of the EORTC criteria  on the basis of cultural or histopathological assessment of the tissue samples at the time the samples were collected. One sample which was PCR-positive from fresh tissue was added to the collection. The samples consisted of 21 lung, 2 skin, one cerebellum, one sinus sphenoidalis, one small intestine, and one soft tissue biopsy (Table 1).
Fungal culture was performed on all 27 biopsy specimens using standard procedures . Isolated fungal organisms were identified by standard phenotypic procedures . Confirmatory molecular identification was performed using the MicroSeq™ D2 rDNA Fungal Identification System (Life technologies™, Rotkreuz, Switzerland) . In addition to the sequence data base of MicroSeq, we compared our sequences using the BLAST analysis search (National Center of Biotechnology Information, Washington DC, www.ncbi.nlm.nih.gov/BLAST).
All samples were obtained during procedures performed in an operation theater supplied with laminar airflow. The samples were transported in sterile containers and fixed in 4% buffered formalin. After paraffin-embedding, biopsies were cut into 4 μm sections, routinely stained with haematoxylin and eosin, elastic-Van Gieson and alcian blue periodic acid-Shiff and reviewed by a pathologist. If there were histological findings suggestive of a fungal infection Grocott’s methenamine silver staining was performed additionally.
Panfungal PCR assay from FFPE biopsies
Deparaffinization and DNA extraction
Three 20 μm tissue slices from each tissue block were transferred to a sterile 1.5 ml vial. 1 ml of xylol was added and incubated for 5 minutes. Xylol was discarded by pipetting after a centrifugation step of 14 000 rpm during 1 minute. Then 1 ml ethanol was added and incubated at room temperature for 1 minute. The ethanol was discarded by pipetting after a centrifugation step as mentioned above. Deparaffinized tissue specimens were dried in a SpeedVac (Savant AES1010) for 20 minutes. DNA was extracted and purified using QIAamp Mini Kit (Qiagen, Hombrechtikon, Switzerland) according to the manufacturer’s instructions with the exception of an additional heating step of 95°C for 12 minutes after pipetting 200 μl AL buffer. All FFPE tissue samples were incubated over night in proteinase K and ATL buffer at 56°C. The elution step was performed with 100 μl AE buffer. Extracted DNA was stored at −20°C.
PCR amplification of ITS1-2 and ITS2 followed by sequencing
Panfungal PCR was performed using primers ITS5 (forward) and ITS4 (reverse) for amplification of ITS region 1 and 2 and primers ITS3 (forward) and ITS4 (reverse) for detection of ITS region 2 . PCR was performed in a total volume of 30 μl consisting of 0.2 μm of each primer and 15 μl of 2× HotStarTaq Master Mix (Qiagen). Four different volumes of DNA extract (0.5, 2, 5, and 10 μl) per sample were analyzed. AE Buffer was added accordingly to the PCR premix to reach the final volume of 30 μl. The PCR amplification program included an initial denaturation at 95°C for 15 minutes, followed by 45 cycles of denaturation at 94°C for 30 seconds, annealing at 58°C for 1 minute, and extension at 72°C for 1 minute. Final elongation was at 72°C for 7 minutes. The PCR reactions were run on a PE 2400 or on a Veriti™ using the 9600 emulation mode (Life technologies™). The PCR products were visualized on a UV transilluminator after electrophoresis on precast 3% ReadyAgarose™ gels (Bio-Rad, Reinach, Switzerland).
The PCR products were purified with Microcon PCR Filter Units (Millipore, Zug, Switzerland) and were sequenced in both directions using the PCR primers and the BigDye® Terminator version1.1 Cycle Sequencing Kit (Life technologies™). After a purification step with DyeEx 2.0 Spin Kit (Qiagen), the sequencing products were detected in an ABI PRISM 3100 genetic analyzer (Life technologies™). The sequences were edited and aligned using the SeqMan sequence analysis software (DNASTAR, Madison, USA) and compared with reference sequences using the BLAST analysis search (National Center of Biotechnology Information, Washington DC, www.ncbi.nlm.nih.gov/BLAST) as well as the search tool of the Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands (CBS) as follows: www.cbs.knaw.nl/collections/BioloMICSSequences.aspx.
Inhibition control using C. krusei-spiking
Inhibition of PCR amplification was evaluated by spiking of 2 μl C. krusei DNA to each PCR premix including 2 μl of sample extract to reach a good visible PCR product after PCR of ITS2 region followed by agarose gel electrophoresis.
Identification of contaminating DNA
Despite strict measures to prevent DNA contamination, we detected erratically small amounts of contaminating DNA in negative extraction controls during the development of our panfungal PCR assay. These fragments could be identified after sequencing as Malassezia restricta/sympodialis DNA.
Our criteria for a positive panfungal PCR result were two or more positive PCR reactions per clinical sample or a single reproducible PCR signal.
PCR amplification of fragments of the beta-globin gene
To evaluate the quality of the extracted DNA from the FFPE biopsies, 2 μl and 0.5 μl from each DNA extract was used for multiplex PCR amplification resulting in 262 bp (primer pair KM29/KM38), 408 bp (primer pair GH20/GH21), and 860 bp (primer pair TI860F/TI860R) fragments of the beta-globin gene according to . The same method for PCR and agarose gel analysis was used as described above for ITS detection with exception of the annealing step which was at 55°C for 30 sec. This analysis was applied to the 26 clinical specimens representing IFD and the PCR positive sample, but also to 10 FFPE control samples with no suspicion of IFD, which were stored at different time periods from 1 month up to 10 years.
Panfungal PCR assay from fresh biopsies
Fresh biopsies were analyzed identically according to the FFPE samples with 2 exceptions. (1), Tissue lysis from fresh specimens was done at 56°C for up to 3 hours instead of overnight incubation, and (2), PCR amplification and direct sequencing was performed only with the ITS1-2 PCR system using primers ITS5 and ITS4 as described previously .
Evaluation of analytical sensitivity
The sensitivity of our two panfungal PCR tests ITS1-2 and ITS2 was compared with fungal culture using Candida krusei reference strain ATCC14243 as described previously . Briefly, aliquots of 10-fold serial dilutions of C. krusei suspensions were extracted according to the protocol for fresh tissue samples. Corresponding PCR signals measured after agarose gel electrophoresis were then compared with the number of C. krusei cells by culture calculating the amount of organisms per PCR amplification and per CFU/ml.
We also assessed the sensitivity of our broad-range fungal PCR assays with Aspergillus-specific PCR systems which are expected to be more sensitive. Therefore, both panfungal PCR assays (ITS1-2 and ITS2) were tested in an external pilot quality control study (ASPDNA10) from the European Quality Control for Molecular Diagnostics (QCMD) programme for the detection of Aspergillus sp. from blood specimens. The panel included 12 samples containing different amounts of Aspergillus DNA or conidia as well as negative controls.
Patients with proven IFD
We analyzed a total of 26 specimens corresponding to patients with proven IFD and one PCR-positive sample (Table 1). Of these 27 specimens 17 (63.0%) were culture-positive, 5 (18.5%) histopathology-positive and culture-negative, and 5 (18.5%) were PCR-positive analyzing fresh biopsies but culture-negative. In all 5 samples with cultural or molecular detection of Hormographiella aspergillata the histopathological report was Aspergillus like dichotomous branching. The cases from patient 6, 13, and 16 with cultural detection of H. aspergillata have been published previously by Conen et al.  (Table 1).
PCR analysis of FFPE specimens
PCR amplification and identification in 14 (51.9%) of the 27 FFPE specimens were positive: 11 (64.7%) among the 17 culture positive samples, 1 from the 5 histologically positive, culture negative- and 2 among the 5 PCR-positive, culture-negative FFPE tissue samples (Table 1).
Organisms identified by PCR corresponded to the results of culture and of PCR from fresh tissues. We noticed two differing results; detection of H. aspergillata in the FFPE sample from patient no. 1 and A. lentulus in the sample from patient no. 3 from which A. nidulans and A. fumigatus were grown on culture respectively. In the first case we repeated the whole analysis including DNA extraction using a second aliquot from formalin-fixed tissue and could confirm the PCR result with a 100% identity to H. aspergillata reference strains. In the sample from patient no. 3 ITS2 PCR and sequencing resulted in a 349-basepair-long sequence with a 100% match to two A. lentulus reference sequences (accession no. EF669968, EF 669970). Because the ITS region is not discriminative enough to identify this organism to the species level, we designated our molecular result as “probably” A. lentulus . In patient 8, the cultural finding of Rhizopus sp. has been improved by PCR to R. microsporus/azygosporus. Specification to the species level of Alternaria in the specimen from patient 10 was not possible with conventional identification procedures or with ITS-based PCR.
In the total of 27 FFPE samples ITS2- and ITS1-2 panfungal PCR were positive in 51.8% and 37% respectively.
As can be seen in Table 2, the best performance to achieve a positive PCR signal was the use of 0.5 μl DNA extract for ITS-2 PCR. The sequence lengths analyzed from ITS1-2 and ITS2 system were from 408 to 641, and 342 to 384 nucleotides, respectively. The quality of the sequences was generally high with one exception of the ITS1-2 fragment using 5 μl extract from patient 3 resulting in 115 nucleotides, allowing only identification as Aspergillus sp (see also Table 3).
Quality of the extracted DNA from FFPE biopsies
We detected inhibition of PCR amplification using spiking with C. krusei DNA in about the half of the samples, suggesting that inhibiting substances might be co-eluted during extraction and purification of the FFPE samples (data not shown). As shown in Table 3, 17 of the 27 samples exhibited DNA degradation based on partial beta-globin gene amplification. A relation between DNA degradation and time of storage of the FFPE tissue specimens was observed. All specimens stored longer than 3 years showed DNA degradation. This phenomenon was also observed in the 10 control samples with no suspicion of IFD (data not shown). In contrast, our results of ITS-based detection of fungal organisms were not related to the beta-globin findings and consequently not dependent on the duration of FFPE storage; in 8 of 13 samples which were stored longer than 3 years and showing DNA degradation, a fungal organism could be identified (Table 3).
Contaminating DNA identified as Malassezia restricta/sympodialis was found in 6 PCR reactions from 5 different specimens. Identical DNA sequences also were rarely identified in our negative extraction controls. The 5 organisms Torrubiella sp, Liphiostoma sp., Panellus stipticus, Davidiella sp., and Coniosporium sp. were detected only in single PCR reactions originating from 5 samples and identification of these organisms could not be confirmed in a repeated testing.
The analytical sensitivity compared to culture was 0.3 Candida krusei organisms per amplification, corresponding to 60 CFU/ml for both ITS-based PCR assays.
The results of the quality control panel from QCMD, Glasgow, Scotland for the detection of Aspergillus DNA including our panfungal PCR results are shown in Table 4. In comparison to the results of the 27 participating laboratories that performed genus-specific PCR tests, our two panfungal PCR assays showed a considerable proficiency.
Applying the panfungal PCR to 26 FFPE samples from patients with proven IFD and to one PCR-positive sample, we found a sensitivity of 53.8% in total and 64.7% in culture-positive specimens according to the EORTC criteria. The ITS2 PCR targeting the shorter fragment showed a higher detection rate with a sensitivity of 53.8% compared to the ITS1-2 fragment (sensitivity 38%). Both assays proved to display a high analytical sensitivity detecting 60 CFU/ml C. krusei. Moreover, the 2 tests reached a considerable result in an Aspergillus proficiency panel from QCMD intended for use in Aspergillus-specific PCR assays.
An important factor which may have influenced the sensitivity might be the composition of fungal organisms detected. Two studies clearly showed that the sensitivity is significantly elevated when yeasts and not only filamentous fungi were identified, suggesting that yeasts can be detected more easily in FFPE samples ,. Accordingly in the study of Rickerts et al. , the sensitivity dropped from 70% to 62% when the cases with yeasts were omitted.
Inhibition of PCR amplification in about one third of the samples - suggesting that inhibiting substances might be co-eluted during extraction and purification of the FFPE samples - might be an additional factor which could be the reason of the only moderate sensitivity of the PCR assays. As can be seen in Table 3 the PCR inhibition was mainly in correlation to the amplification of the human beta-globin gene. In a study of Provan et al.  a PCR product <300 base pairs could only be amplified in 60% of the DNA samples extracted, which suggests that the DNA contained PCR inhibitor and/or was degraded. Bretagne et al.  excluded 3 of 55 bronchoalveolar lavage samples as they did not allow correct amplification of the internal competitive control presumably because of PCR inhibition. Therefore, internal amplification controls are crucial for PCR analysis to rule out false negative results.
In a previous study we have analyzed the diagnostic yield of panfungal PCR on fresh tissue biopsy specimens; in contrast to FFPE specimens, we could show a high sensitivity of the PCR approach on patient level and a higher positive rate compared to culture and/or histology . These results additionally support the finding that formaldehyde inhibits fungal PCR.
In our study, we used different volumes of sample DNA to improve the efficiency of the two conventional PCR assays. We showed that this approach was an important factor for accurate detection of fungal pathogens in FFPE samples including the identification of contaminating DNA.
In concordance to the studies of Muñoz-Cadavid et al. and Cabaret et al. , we found a higher detection rate in the PCR system amplifying the shorter fragment, demonstrating degradation of fungal DNA in FFPE tissue. Muñoz-Cadavid et al. used identical primer pairs and found 38 and 65 positive samples for ITS1-2 and ITS2 PCR, respectively. The difference in performance between our two PCR assays may be caused by the effect of degradation, having greater influence on larger PCR applicants. Cabaret et al. analyzed 16 FFPE sinus fungal balls. Ten were positive using ITS-based PCR detecting a PCR fragment >300 bp, whereas mitochondrial PCR amplifying <150 bp was positive in 15 from 16 specimens. The authors consequently concluded that ITS-based identification cannot be used as a single detection system in FFPE samples with suspicion of IFD.
We observed a high amount of FFPE samples with DNA degradation measured with beta-globin gene amplification. According to other studies ,, the degradation of the human DNA was time dependent, with significant degradation in samples older than 3 years. Crosslinking between nucleic acid and proteins might be another reason, resulting in base pair lengths of approximately 200 bp or less, as this has been described in samples treated with formaldehyde . On the contrary, PCR amplification including correct identification of fungal DNA was astonishingly not age-dependent and, to our knowledge, is reported for the first time in this study (Table 3). A possible explanation for this finding could be a protective effect of the tenacious fungal cell wall against formalin.
In our series a discrepant PCR result was detected compared to culture; H. aspergillata was detected on molecular level in the FFPE lung tissue from patient 1 which had been stored for 7 years and in which A. nidulans had been detected in culture. Infection with H. aspergillata has been reported from several critically ill patients -, including from our institution describing the cases from patient 6, 13, and 16 in this study . Antifungal therapy options are limited as there is limited activity of caspofungin and none of fluconazole . Our patient was successfully treated with voriconazole. Retrospectively, mixed or concomitant infection in patient 1 could have been present which might not have been detected by the conventional diagnostic methods; pre-treatment with antifungals may lower the culture yield and fungal elements in tissue samples may often appear as pleomorphic, impeding diagnosis of mixed infections and representing diagnostic challenge.
In patient no. 2 the fungal cultures revealed A. fumigatus and Fusarium sp. Here, only A. fumigatus could be detected by PCR. This might be due to preferential amplification of individual amplicons by the ITS-assay, depending on PCR conditions and primer mismatch, in samples where different templates are present; a phenomenon which is described in 16S rRNA gene-targeting bacterial community analysis .
A further inconsistent finding was the molecular identification of probable A. lentulus in patient 3 with the cultural result of A. fumigatus.
A. lentulus, a new species of Aspergillus, that has morphological characteristics poorly distinguishable from A. fumigatus , was originally described by Balajee et al. in 2005 . Correct species identification only can be accomplished by sequencing of the beta-tubulin and rodlet A gene. A characteristic of A. lentulus is its reduced susceptibility to multiple antifungal drugs -. Interestingly, in this patient’s lung lesions were progressive under therapy with voriconazole. We now hypothesize that in 2006 the patient was infected with A. lentulus, which could not correctly been identified morphologically, and that inefficient antifungal therapy for the causative A. lentulus may have allowed progression. As can be seen in a similar study based on ITS1 PCR from Lau et al. , this organism was detected in further 5 cases.
Limitation and strengths
First, the added value of our results for the identification of fungi in culture negative samples is only limited and the sample size small. Second, the assays were only applied to tissue samples and not tested on less invasive sample types like bronchoalveolar lavage. However, the study was conducted to test the performance of the assays against proven cases of IFD according to EORCT criteria (with the exception of sample 25) and to test the accuracy of identification of fungal pathogens in FFPE samples.
Furthermore the overall methodology of the study might only be satisfactory because of a fairly low sensitivity of 53.8%. However we have studied limiting factors of performing panfungal PCR on FFPE tissues in a meticulous way and have reviewed patient’s clinical histories in detail, especially in cases where PCR results differed from cultural results.
To conclude, panfungal diagnostic PCR assays applied to FFPE specimens provide accurate identification of molds in highly degraded tissue samples and correct identification in samples stored up to 7 years despite limitations in sensitivity mainly caused by PCR inhibition and DNA degradation of formalin. One of the main disadvantages of molecular approaches in FFPE specimens might be the contamination with ubiquitous environmental fungi. However, in combination with conventional laboratory test methods panfungal PCR may increase diagnostic yield, especially in culture-negative samples and might complement conventional diagnostic tests particularly in cases of mixed infections. The added value for the identification of culture-negative samples though is limited in this study and studies with higher sample sizes are necessary.
Barnes RA: Early diagnosis of fungal infection in immunocompromised patients. J Antimicrob Chemother. 2008, 61 (Suppl 1): i3-i6. 10.1093/jac/dkm424.
Auberger J, Lass-Florl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, Einsele H, Gastl G, Nachbaur D: Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2008, 88 (5): 508-515. 10.1007/s12185-008-0184-2.
Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyiannis DP: Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol. 2003, 119 (6): 854-858. 10.1309/EXBVYAUPENBM285Y.
Greer CE, Wheeler CM, Manos MM: Sample preparation and PCR amplification from paraffin-embedded tissues. Genome Res. 1994, 3: S113-S122. 10.1101/gr.3.6.S113.
Inadome Y, Noguchi M: Selection of higher molecular weight genomic DNA for molecular diagnosis from formalin-fixed material. Diagn Mol Pathol. 2003, 12 (4): 231-236. 10.1097/00019606-200312000-00007.
White TBT, Lee S, Taylor JW: Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. 1990, Academic Press, San Diego
Cabaret O, Toussain G, Abermil N, Alsamad IA, Botterel F, Costa JM, Papon JF, Bretagne S: Degradation of fungal DNA in formalin-fixed paraffin-embedded sinus fungal balls hampers reliable sequence-based identification of fungi. Med Mycol. 2011, 49 (3): 329-332. 10.3109/13693786.2010.525537.
Lau A, Chen S, Sorrell T, Carter D, Malik R, Martin P, Halliday C: Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol. 2007, 45 (2): 380-385. 10.1128/JCM.01862-06.
Munoz-Cadavid C, Rudd S, Zaki SR, Patel M, Moser SA, Brandt ME, Gomez BL: Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR. J Clin Microbiol. 2010, 48 (6): 2147-2153. 10.1128/JCM.00459-10.
Paterson PJ, Seaton S, McHugh TD, McLaughlin J, Potter M, Prentice HG, Kibbler CC: Validation and clinical application of molecular methods for the identification of molds in tissue. Clin Infect Dis. 2006, 42 (1): 51-56. 10.1086/498111.
Rickerts V, Khot PD, Myerson D, Ko DL, Lambrecht E, Fredricks DN: Comparison of quantitative real time PCR with Sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens. BMC Infect Dis. 2011, 11: 202-10.1186/1471-2334-11-202.
Willinger B, Obradovic A, Selitsch B, Beck-Mannagetta J, Buzina W, Braun H, Apfalter P, Hirschl AM, Makristathis A, Rotter M: Detection and identification of fungi from fungus balls of the maxillary sinus by molecular techniques. J Clin Microbiol. 2003, 41 (2): 581-585. 10.1128/JCM.41.2.581-585.2003.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sorrell JD, Sobel JD, Sorrell TC, Viscoli C, et al: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group . Clin Infect Dis. 2008, 46 (12): 1813-1821. 10.1086/588660.
Clinical microbiology procedures handbook, 3rd edn. USA: ASM Press Washington; 2010.
De Hoog GS, Guarro J, Gené J, Figueras MJ: Atlas of clinical fungi, 2nd and 3rd edn.
Hall L, Wohlfiel S, Roberts GD: Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory. J Clin Microbiol. 2004, 42 (2): 622-626. 10.1128/JCM.42.2.622-626.2004.
Babouee B, Goldenberger D, Elzi L, Lardinois D, Sadowski-Cron C, Bubendorf L, Savic Prince S, Battegay M, Frei R, Weisser M: Prospective study of a panfungal PCR assay followed by sequencing, for the detection of fungal DNA in normally sterile specimens in a clinical setting: a complementary tool in the diagnosis of invasive fungal disease?. Clin Microbiol Infect. 2013, 19 (8): E354-E357. 10.1111/1469-0691.12231.
Goldenberger D, Perschil I, Ritzler M, Altwegg M: A simple “universal” DNA extraction procedure using SDS and proteinase K is compatible with direct PCR amplification. PCR Methods Appl. 1995, 4 (6): 368-370. 10.1101/gr.4.6.368.
Conen A, Weisser M, Hohler D, Frei R, Stern M: Hormographiella aspergillata: an emerging mould in acute leukaemia patients? Clin Microbiol Infect 2010.,
Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA: Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell. 2005, 4 (3): 625-632. 10.1128/EC.4.3.625-632.2005.
Provan AB, Hodges E, Smith AG, Smith JL: Use of paraffin wax embedded bone marrow trephine biopsy specimens as a source of archival DNA. J Clin Pathol. 1992, 45 (9): 763-765. 10.1136/jcp.45.9.763.
Bretagne S, Costa JM, Marmorat-Khuong A, Poron F, Cordonnier C, Vidaud M, Fleury-Feith J: Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol. 1995, 33 (5): 1164-1168.
Kuykendall JR, Bogdanffy MS: Efficiency of DNA-histone crosslinking induced by saturated and unsaturated aldehydes in vitro. Mutat Res. 1992, 283 (2): 131-136. 10.1016/0165-7992(92)90145-8.
Abuali MM, Posada R, Del Toro G, Roman E, Ramani R, Chaturvedi S, Chaturvedi V, LaBombardi VJ: Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J Clin Microbiol. 2009, 47 (12): 4176-4179. 10.1128/JCM.00305-09.
Lagrou K, Massonet C, Theunissen K, Meersseman W, Lontie M, Verbeken E, Van Eldere J, Maertens J: Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata. J Med Microbiol. 2005, 54 (Pt 7): 685-688. 10.1099/jmm.0.46016-0.
Verweij PE, van Kasteren M, van de Nes J, de Hoog GS, de Pauw BE, Meis JF: Fatal pulmonary infection caused by the basidiomycete Hormographiella aspergillata. J Clin Microbiol. 1997, 35 (10): 2675-2678.
Conen A, Weisser M, Hohler D, Frei R, Stern M: Hormographiella aspergillata: an emerging mould in acute leukaemia patients?. Clin Microbiol Infect. 2011, 17 (2): 273-277. 10.1111/j.1469-0691.2010.03266.x.
Sipos R, Szekely AJ, Palatinszky M, Revesz S, Marialigeti K, Nikolausz M: Effect of primer mismatch, annealing temperature and PCR cycle number on 16S rRNA gene-targetting bacterial community analysis. FEMS Microbiol Ecol. 2007, 60 (2): 341-350. 10.1111/j.1574-6941.2007.00283.x.
Balajee SA, Nickle D, Varga J, Marr KA: Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping. Eukaryot Cell. 2006, 5 (10): 1705-1712. 10.1128/EC.00162-06.
Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL: Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob Agents Chemother. 2008, 52 (4): 1244-1251. 10.1128/AAC.00942-07.
Alhambra A, Catalan M, Moragues MD, Brena S, Ponton J, Montejo JC, del Palacio A: Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease. Rev Iberoam Micol. 2008, 25 (4): 246-249. 10.1016/S1130-1406(08)70058-5.
We thank Elisabeth Schultheiss for excellent technical assistance in sequencing and analysis of QCMD samples and Alexander Rufle for the deparaffinization of all 27 FFPE samples. We kindly acknowledge Juergen Loeffler for critical review of the manuscript. Further we thank Luigia Elzi for her scientific help and support and Thomas J. Armstrong for linguistic review of the manuscript.
Parts of this study have been published at the 21st European Congress of Clinical Microbiology and Infectious Diseases in Milano/Italy, 7 – 10 May 2011.
The authors declare that they have no competing interests.
BBF has carried out the molecular tests, made substantial contributions to interpretation of data and drafted the manuscript. MW has made contribution to collection of data and revised the manuscript critically. SSP and LB have carried out the histological examinations and made substantial contributions to interpretation of data. RF has helped to concept the study and made substantial contribution in data interpretation. MB has made substantial contribution in data interpretation and revised the manuscript critically. DG has designed and concepted the study, carried out microbiological exams and helped to draft the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Babouee Flury, B., Weisser, M., Prince, S.S. et al. Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors?. BMC Infect Dis 14, 692 (2014). https://doi.org/10.1186/s12879-014-0692-z
- Panfungal PCR
- Internal transcribed spacer (ITS)
- Invasive fungal disease
- Formalin-fixed paraffin-embedded tissue
- Analytical sensitivity
- Beta-globin gene